PCV6 AN ECONOMIC EVALUATION OF CLOPIDOGREL VS. ASPIRIN IN SECONDARY PREVENTION OF ISCHEMIC EVENTS IN HIGH RISKATHEROTHROMBOTIC PATIENTS IN ITALY